Seattle Genetics
Clay B. Siegall, Ph.D. — President and Chief Executive Officer
Eric L. Dobmeier — Chief Operating Officer
Thomas C. Reynolds, M.D., Ph.D. — Chief Medical Officer
Todd E. Simpson — Chief Financial Officer
Vaughn B. Himes, Ph.D. — Executive VP, Process Sciences and Technical Operations
Chris Boerner, Ph.D. — Senior VP, Commercial
Jonathan Drachman, M.D. — Senior VP, Research and Translational Medicine
Christopher Pawlowicz — Senior VP, Human Resources
Elaine Waller, Pharm.D. — Senior VP, Regulatory Affairs
James Kyle Bryan, M.D. — VP, Medical Affairs
Jorge Cerda — VP, Information Technology
Darren Cline — VP, Marketing, Managed Markets and Reimbursement
Natasha Hernday — VP, Corporate Development
Charles R. Romp — VP, Sales
Kirk D. Schumacher — VP, Legal Affairs & Compliance and General Counsel
Peter D. Senter, Ph.D. — VP, Chemistry and Distinguished Fellow
Eric Sievers, M.D. — VP, Clinical Affairs
Charles Smith — VP, Quality
Samuel Yonren, M.D. — VP, Drug Safety
Clay B. Siegall, Ph.D.
Srinivas Akkaraju, M.D., Ph.D
Felix Baker, Ph.D.
Franklin M. Berger, CFA
David W. Gryska
Marc E. Lippman, M.D.
John P. McLaughlin
Nancy A. Simonian, M.D.
Daniel G. Welch